Vol. 11 No. 1 (2004)

Published: 2004-10-01

Editorial

Editorial: Are clinical trial authorisations truly being harmonised?

Linda R Horton
- PDF

Article

Bioentrepreneurship in Japan: Institutional transformation and the growth of bioventures

Michael J Lynskey
- PDF
Changes to the European Union pharmaceutical legislation: Implications of the 'Pharma Review' for biotechnology companies

Erkki Liikanen
- PDF
A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on pharmacovigilance

Graeme Ladds
- PDF
Interference basics

Thomas J Kowalski, William F Lawrence, Samuel H Megerditchian
- PDF
Where will industry go to for its high-calibre staff?

Faiz Kermani, Rebecca Gittins
- PDF
Cross-border transactions: A roadmap for commercial arrangements between North American and European companies

Raymond S Fersko, Hind Merabet, Valentina Cordioli
- PDF
Biotech blockbuster forecasts to 2008

Alex K Pavlou, Mark Belsey
- PDF

Legal and Regulatory Updates

Regulatory data protection for medicines

John Wilkinson, Frederick J Dorey
- PDF
Financial accounts reports

Colin Aaronson
- PDF